BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rohner NA, Schomisch SJ, Marks JM, von Recum HA. Cyclodextrin Polymer Preserves Sirolimus Activity and Local Persistence for Antifibrotic Delivery over the Time Course of Wound Healing. Mol Pharm 2019;16:1766-74. [PMID: 30807185 DOI: 10.1021/acs.molpharmaceut.9b00144] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Dogan AB, Dabkowski KE, von Recum HA. Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics. Pharmaceutics 2022;14:1088. [DOI: 10.3390/pharmaceutics14051088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Dhingra S, Sharma S, Saha S. Infection Resistant Surface Coatings by Polymer Brushes: Strategies to Construct and Applications. ACS Appl Bio Mater . [DOI: 10.1021/acsabm.1c01006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Young K, Dogan AB, Hernandez C, Exner AA, von Recum HA. Conventional polymers may unintentionally refill in vivo with unassociated drugs.. [DOI: 10.1101/2022.03.21.485180] [Reference Citation Analysis]
4 Dogan AB, Rohner NA, Smith JNP, Kilgore JA, Williams NS, Markowitz SD, von Recum HA, Desai AB. Polymer Microparticles Prolong Delivery of the 15-PGDH Inhibitor SW033291. Pharmaceutics 2021;14:85. [PMID: 35056981 DOI: 10.3390/pharmaceutics14010085] [Reference Citation Analysis]
5 Gandhi S, Shende P. Cyclodextrins-modified metallic nanoparticles for effective cancer therapy. J Control Release 2021;339:41-50. [PMID: 34560156 DOI: 10.1016/j.jconrel.2021.09.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
6 Dogan AB, Rohner NA, Smith JN, Kilgore JA, Williams NS, Markowitz SD, von Recum HA, Desai AB. Polymer microparticles prolong delivery of the 15-PGDH inhibitor SW033291.. [DOI: 10.1101/2021.08.15.456403] [Reference Citation Analysis]
7 Young K, Lord AE, Burkhart GE, Kozawa SK, Mu N, von Recum HA. Simple degradable cyclodextrin polyester with chelator-based crosslinker for stent-based drug delivery.. [DOI: 10.1101/2021.04.29.442054] [Reference Citation Analysis]
8 Dogan A, Dabkowski K, von Recum H. Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics.. [DOI: 10.1101/2020.12.03.410621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Rohner NA, Purdue LN, von Recum HA. Affinity-Based Polymers Provide Long-Term Immunotherapeutic Drug Delivery Across Particle Size Ranges Optimal for Macrophage Targeting. J Pharm Sci 2021;110:1693-700. [PMID: 33127427 DOI: 10.1016/j.xphs.2020.10.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rivera-Delgado E, Learn GD, Kizek DJ, Kashyap T, Lai EJ, von Recum HA. A Polymeric Delivery System Enables Controlled Release of Genipin for Spatially-Confined In Situ Crosslinking of Injured Connective Tissues. J Pharm Sci 2021;110:815-23. [PMID: 33190799 DOI: 10.1016/j.xphs.2020.09.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Dogan A, von Recum H. Engineering selective molecular tethers to enhance suboptimal drug properties. Acta Biomater 2020;115:383-92. [PMID: 32846237 DOI: 10.1016/j.actbio.2020.07.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
12 McBride DA, Kerr MD, Wai SL, Yee YY, Ogbonna DA, Shah NJ. Characterization of regulatory T cell expansion for manufacturing cellular immunotherapies. Biomater Sci 2020;8:4186-98. [PMID: 32441280 DOI: 10.1039/d0bm00622j] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Haley RM, Zuckerman ST, Dakhlallah H, Capadona JR, von Recum HA, Ereifej ES. Resveratrol Delivery from Implanted Cyclodextrin Polymers Provides Sustained Antioxidant Effect on Implanted Neural Probes. Int J Mol Sci 2020;21:E3579. [PMID: 32438593 DOI: 10.3390/ijms21103579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 Tian B, Liu Y, Liu J. Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems. Carbohydr Polym 2020;242:116401. [PMID: 32564836 DOI: 10.1016/j.carbpol.2020.116401] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
15 Rohner NA, Nguyen D, von Recum HA. Affinity Effects on the Release of Non-Conventional Antifibrotics from Polymer Depots. Pharmaceutics 2020;12:E275. [PMID: 32192207 DOI: 10.3390/pharmaceutics12030275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Dogan AB, von Recum HA. Engineering Selective Molecular Tethers to Enhance Suboptimal Drug Properties.. [DOI: 10.1101/2020.02.01.929356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Tian B, Liu J. The classification and application of cyclodextrin polymers: a review. New J Chem 2020;44:9137-48. [DOI: 10.1039/c9nj05844c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
18 Rohner NA, Purdue L, von Recum HA. Affinity-based polymers provide long-term immunotherapeutic drug delivery across particle size ranges optimal for macrophage targeting.. [DOI: 10.1101/802801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]